(CercleFinance.com) – Mauna Kea Technologies announces a new partnership with Metrodora Institute, a leading multidisciplinary health institute.
This collaboration aims to make the Metrodora Institute the first American center of excellence which will serve as a model for patient care and training of doctors in the use of Cellvizio in the identification and treatment of food intolerances in patients suffering from irritable bowel syndrome (IBS).
‘This partnership is perfectly aligned with our strategic vision and represents a significant step forward in the expansion of the use of Cellvizio in the field of food intolerances,’ said Sacha Loiseau, Ph.D., Founder, Chairman and CEO of Mauna Kea Technologies.
According to him, this collaboration ‘constitutes an essential lever in raising awareness of C-FIT among the medical community and patients, positioning it as a reference method for the detection of food intolerances’,